Danielle Guarneri

Safety and efficacy of plerixafor dose escalation for the mobilization of CD34 ⁺ hematopoietic progenitor cells in patients with sickle cell disease: interim results

Farid Boulad, Tsiporah B. Shore, Koen van Besien et al. · Haematologica · 2018 · 60 citations · Full text

Medicine, Hematology, Pharmacology +14

Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk

Koen van Besien, Lizamarie Bachier‐Rodriguez, Michael J. Satlin et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 34 citations

Life Sciences, Hematology, Immunology +15

Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning

Koen van Besien, Andrew Artz, Richard E. Champlin et al. · Blood Advances · 2019 · 34 citations · Full text

Medicine, Hematology, Immunology +16

High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma

Alexandra Gomez-Arteaga, Tomer M. Mark, Danielle Guarneri et al. · Bone Marrow Transplantation · 2019 · 23 citations

Medicine, Hematology, Oncology +17

A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma

Tomer M. Mark, Danielle Guarneri, Peter A. Forsberg et al. · Biology of Blood and Marrow Transplantation · 2017 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +17